October 3, 2012

Flulapalooza set for Oct. 17-18

By Nancy Humphrey

July 19, 2012

Long antibodies better against HIV

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

By Leigh MacMillan

April 27, 2012

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.

By Vanderbilt Health News

April 13, 2012

Researchers spot Achilles’ heel in respiratory virus

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.

By Leigh MacMillan

February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

By Vanderbilt Health News

October 7, 2011

Diversity key in antibody repertoire

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

By Vanderbilt Health News